Weight gain with psychotropic drugs.pptx

Weight gain with
psychotropic drugs
By
Dr Mohammud Ibraheem
Mechanism
1.5HT2A/2C
antagonism
2.Antihistaminic
effects
3.Insulin resistance
Serotonergic Receptors
Serotonin receptors are 7 types, 5-HT1
through 5-HT7. Each type can have
subtypes (A, B, etc.).
They are localized in the brain and in
peripheral organs. The majority of 5-HT
receptors are postsynaptic.
5-HT1A and 5-HT1B are mainly presynaptic
Serotonin receptors are coupled to G
proteins except 5-HT3 receptors which are
ion channel.
Sites of 5-HT2A receptors
5-HT2A receptors are found in::
1. High density in the claustrum
2. Limbic system (amygdala and
hippocampus)
3. The basal ganglia
5HT2A
Agonist Antagonists
1. Efavirenz (an
antiretroviral drug)
2. Lisuride (an
antiparkinson dopamine
agonist)
3. Mefloquine (an
antimalarial drug)
4. lorcaserin
5. lumateperone
1. Trazodone
2. Tricyclic antidepressants:
Amitriptyline, Nortriptyline,
Amoxapine, Clomipramine,
Doxepin, Maprotiline, Imipramine
3. Tetracyclic antidepressants:
Mianserin, Mirtazapine
4. Ketanserin
5. Antipsychotics ; Cariprazine,
clozapine, olanzapine, quetiapine,
risperidone, brexpiprazole,
asenapine, haloperidol and
chlorpromazine
6. Cyproheptadine
Sites of 5HT2C receptors
5HT2C receptors are expressed in:
1) The nucleus accumbens
2) Caudate putamen
3) Olfactory tubercle
4) Claustrum, cingular cortex, amygdala
5) Dentate gyrus, periaqueductal gray,
entorhinal cortex, some brainstem motor
nuclei
5HT2C
Agonists Antagonists
1. Fenfluramine (Dravet
syndrome and Lennox–
Gastaut syndrome)
2. Lorcaserin
3. Arpiprazole ( partial
agonist)
1. Agomelatine
2. Flibanserin (pre-
menopausal hypoactive
sexual desire disorder)
3. Fluoxetine
4. Mirtazapine
5. Trazodone
H1 antagonisms
a) Tricyclic antidepressants;; DOXEPIN the
most potent antihistaminic, the second
potent is amitrptalin, the less potent is
desipramine.
b) Mirtazepine
c) Mianserin
d) Antipsychotics; Ziprasidone, risperidone,
olanzapine, clonzapine, iloperidone and
cariprazine
Insulin resistance
I. Antipsychotics; olanzapine, clozapine,
risperidone, qutiapine, ziprasidone,
arpiprazole
II. Mood stabilizers; valporic acide
Low potency antipsychotics
(chlorpromazine and
thioridazine) produce more
weight gain and sedation
than high potency agents
(haloperidol and
fluphenazine).
Mean weight increases during the first year
of therapy
1. 12 to 14lb for clozapine (5 to 6 kg)
2. 15 to 26lb for olanzapine (7 to 12kg)
3. 6 to 12lb for quetiapine (2.5 to 5kg)
4. Up to 5lb for risperidone (2 to 2.5kg)
5. Less than 2lb for Ziprasidone and
aripiprazole
Thank you
1 de 12

Mais conteúdo relacionado

Similar a Weight gain with psychotropic drugs.pptx

Serotonin & Their antagonistsSerotonin & Their antagonists
Serotonin & Their antagonistsRAJNEESH KUMAR SINGH
18.6K visualizações27 slides
5-Hydroxytrptamine & it's Antagonist5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's AntagonistShubham Patil
17.3K visualizações22 slides
AutocoidsAutocoids
AutocoidsSujit Karpe
6.7K visualizações49 slides
5-Hydroxytyptamine (Serotonin)5-Hydroxytyptamine (Serotonin)
5-Hydroxytyptamine (Serotonin)Ibrahim Hussein
12.7K visualizações46 slides
AutocoidsAutocoids
AutocoidsRavish Yadav
1.1K visualizações74 slides
Serotonergic system raviSerotonergic system ravi
Serotonergic system raviPrashant Mishra
4.8K visualizações58 slides

Similar a Weight gain with psychotropic drugs.pptx(20)

Serotonin & Their antagonistsSerotonin & Their antagonists
Serotonin & Their antagonists
RAJNEESH KUMAR SINGH18.6K visualizações
5-Hydroxytrptamine & it's Antagonist5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's Antagonist
Shubham Patil17.3K visualizações
AutocoidsAutocoids
Autocoids
Sujit Karpe6.7K visualizações
5-Hydroxytyptamine (Serotonin)5-Hydroxytyptamine (Serotonin)
5-Hydroxytyptamine (Serotonin)
Ibrahim Hussein12.7K visualizações
AutocoidsAutocoids
Autocoids
Ravish Yadav1.1K visualizações
Serotonergic system raviSerotonergic system ravi
Serotonergic system ravi
Prashant Mishra4.8K visualizações
Serotonin receptorsSerotonin receptors
Serotonin receptors
FarazaJaved31.8K visualizações
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
AliLaith52304.7K visualizações
Hanipsych, serotonine and depressionHanipsych, serotonine and depression
Hanipsych, serotonine and depression
Hani Hamed253 visualizações
histamin (1).pptxhistamin (1).pptx
histamin (1).pptx
myLord36 visualizações
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists Pharmacology
PranatiChavan3.6K visualizações
neurohumoraltransmissionincns-210526115354.pdfneurohumoraltransmissionincns-210526115354.pdf
neurohumoraltransmissionincns-210526115354.pdf
Singhchinu11 visualizações
Neurohumoral transmission in CNSNeurohumoral transmission in CNS
Neurohumoral transmission in CNS
Sanchit Dhankhar15.3K visualizações
5-HT and their Antagonist.pdf5-HT and their Antagonist.pdf
5-HT and their Antagonist.pdf
rishi278985 visualizações
5-HT Pharmacology - drdhriti5-HT Pharmacology - drdhriti
5-HT Pharmacology - drdhriti
http://neigrihms.gov.in/55K visualizações
Serotonin Serotonin
Serotonin
Tehran University of Medical Sciences37.8K visualizações
Serotonin and migraineSerotonin and migraine
Serotonin and migraine
Ankita Bist71 visualizações
Serotonin and its role in psychiatry.pptxSerotonin and its role in psychiatry.pptx
Serotonin and its role in psychiatry.pptx
AdityaAgrawal238211 visualizações
Antidepressants.pptxAntidepressants.pptx
Antidepressants.pptx
FAZAIA RUTH PFAU MEDICAL COLLEGE ,KARACHI,PAKISTAN13 visualizações

Mais de MohamadAlhes

Fabry disease.pptxFabry disease.pptx
Fabry disease.pptxMohamadAlhes
200 visualizações43 slides
Diagnosing Secondary.pptxDiagnosing Secondary.pptx
Diagnosing Secondary.pptxMohamadAlhes
105 visualizações46 slides
Natalizumab.pptxNatalizumab.pptx
Natalizumab.pptxMohamadAlhes
255 visualizações27 slides

Mais de MohamadAlhes(9)

Cardiopulmonary complications of SAHCardiopulmonary complications of SAH
Cardiopulmonary complications of SAH
MohamadAlhes20 visualizações
Hutchinson-Gilford Progeria Syndrome.ppsxHutchinson-Gilford Progeria Syndrome.ppsx
Hutchinson-Gilford Progeria Syndrome.ppsx
MohamadAlhes155 visualizações
Subarachnoid hemorrhage, part1.pptxSubarachnoid hemorrhage, part1.pptx
Subarachnoid hemorrhage, part1.pptx
MohamadAlhes129 visualizações
Fabry disease.pptxFabry disease.pptx
Fabry disease.pptx
MohamadAlhes200 visualizações
Diagnosing Secondary.pptxDiagnosing Secondary.pptx
Diagnosing Secondary.pptx
MohamadAlhes105 visualizações
Natalizumab.pptxNatalizumab.pptx
Natalizumab.pptx
MohamadAlhes255 visualizações
Middle Cerebral Artery SyndromesMiddle Cerebral Artery Syndromes
Middle Cerebral Artery Syndromes
MohamadAlhes16 visualizações
Serotonin syndromSerotonin syndrom
Serotonin syndrom
MohamadAlhes24 visualizações
Myasthenia gravis.Myasthenia gravis.
Myasthenia gravis.
MohamadAlhes311 visualizações

Último(20)

DEBATE IN CA BLADDER TMT VS CYSTECTOMYDEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
Kanhu Charan28 visualizações
HEAT TRANSFER.pptxHEAT TRANSFER.pptx
HEAT TRANSFER.pptx
AneriPatwari163 visualizações
Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP24 visualizações
Anaemia,jaundice.pptxAnaemia,jaundice.pptx
Anaemia,jaundice.pptx
Reena Gollapalli13 visualizações
Preparation and Evaluation Ointment.pptxPreparation and Evaluation Ointment.pptx
Preparation and Evaluation Ointment.pptx
Sudhanshu Sagar51 visualizações
Biopharmaceutics.pptxBiopharmaceutics.pptx
Biopharmaceutics.pptx
TsegayeNigussie510 visualizações
 CAPSULE CAPSULE
CAPSULE
Ganapathi Vankudoth57 visualizações
Classification of Cephalosporins.docxClassification of Cephalosporins.docx
Classification of Cephalosporins.docx
Dr. Ajmer Singh Grewal26 visualizações
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905432 visualizações
HYDROCOLLATOR PACK by Dr. Aneri.pptxHYDROCOLLATOR PACK by Dr. Aneri.pptx
HYDROCOLLATOR PACK by Dr. Aneri.pptx
AneriPatwari94 visualizações
 Fastest Growing Pharmaceutical Companies in India Fastest Growing Pharmaceutical Companies in India
Fastest Growing Pharmaceutical Companies in India
Unimarck Pharma India Ltd.32 visualizações
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.
Dr Sanket Nandekar16 visualizações
Virtual Healing: Transforming Healthcare Worker Wellness Through VRVirtual Healing: Transforming Healthcare Worker Wellness Through VR
Virtual Healing: Transforming Healthcare Worker Wellness Through VR
Badalona Serveis Assistencials13 visualizações
Pelvi-ureteric junction obstructionPelvi-ureteric junction obstruction
Pelvi-ureteric junction obstruction
DrArjunPawar27 visualizações
NMP-6.pptxNMP-6.pptx
NMP-6.pptx
Sai Sailesh Kumar Goothy40 visualizações
Pathogenesis of Cell Injury.pptxPathogenesis of Cell Injury.pptx
Pathogenesis of Cell Injury.pptx
Systematic Learning52 visualizações

Weight gain with psychotropic drugs.pptx

  • 1. Weight gain with psychotropic drugs By Dr Mohammud Ibraheem
  • 3. Serotonergic Receptors Serotonin receptors are 7 types, 5-HT1 through 5-HT7. Each type can have subtypes (A, B, etc.). They are localized in the brain and in peripheral organs. The majority of 5-HT receptors are postsynaptic. 5-HT1A and 5-HT1B are mainly presynaptic Serotonin receptors are coupled to G proteins except 5-HT3 receptors which are ion channel.
  • 4. Sites of 5-HT2A receptors 5-HT2A receptors are found in:: 1. High density in the claustrum 2. Limbic system (amygdala and hippocampus) 3. The basal ganglia
  • 5. 5HT2A Agonist Antagonists 1. Efavirenz (an antiretroviral drug) 2. Lisuride (an antiparkinson dopamine agonist) 3. Mefloquine (an antimalarial drug) 4. lorcaserin 5. lumateperone 1. Trazodone 2. Tricyclic antidepressants: Amitriptyline, Nortriptyline, Amoxapine, Clomipramine, Doxepin, Maprotiline, Imipramine 3. Tetracyclic antidepressants: Mianserin, Mirtazapine 4. Ketanserin 5. Antipsychotics ; Cariprazine, clozapine, olanzapine, quetiapine, risperidone, brexpiprazole, asenapine, haloperidol and chlorpromazine 6. Cyproheptadine
  • 6. Sites of 5HT2C receptors 5HT2C receptors are expressed in: 1) The nucleus accumbens 2) Caudate putamen 3) Olfactory tubercle 4) Claustrum, cingular cortex, amygdala 5) Dentate gyrus, periaqueductal gray, entorhinal cortex, some brainstem motor nuclei
  • 7. 5HT2C Agonists Antagonists 1. Fenfluramine (Dravet syndrome and Lennox– Gastaut syndrome) 2. Lorcaserin 3. Arpiprazole ( partial agonist) 1. Agomelatine 2. Flibanserin (pre- menopausal hypoactive sexual desire disorder) 3. Fluoxetine 4. Mirtazapine 5. Trazodone
  • 8. H1 antagonisms a) Tricyclic antidepressants;; DOXEPIN the most potent antihistaminic, the second potent is amitrptalin, the less potent is desipramine. b) Mirtazepine c) Mianserin d) Antipsychotics; Ziprasidone, risperidone, olanzapine, clonzapine, iloperidone and cariprazine
  • 9. Insulin resistance I. Antipsychotics; olanzapine, clozapine, risperidone, qutiapine, ziprasidone, arpiprazole II. Mood stabilizers; valporic acide
  • 10. Low potency antipsychotics (chlorpromazine and thioridazine) produce more weight gain and sedation than high potency agents (haloperidol and fluphenazine).
  • 11. Mean weight increases during the first year of therapy 1. 12 to 14lb for clozapine (5 to 6 kg) 2. 15 to 26lb for olanzapine (7 to 12kg) 3. 6 to 12lb for quetiapine (2.5 to 5kg) 4. Up to 5lb for risperidone (2 to 2.5kg) 5. Less than 2lb for Ziprasidone and aripiprazole